News

Spectral Medical Celebrates Tigris Trial's Enrollment Success

Spectral Medical Celebrates Tigris Trial's Enrollment Success

Spectral Medical Achieves Enrollment for Tigris Trial

TORONTO, April 16, 2025 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), dedicated to advancing treatment options for sepsis and septic shock, is thrilled to announce that it has successfully completed the enrollment phase of its Tigris trial. This Phase 3 clinical study focuses on assessing the efficacy of Polymyxin B Hemoperfusion (“PMX”) for adult patients suffering from endotoxic septic shock, and it marks a pivotal step forward in the Company’s research endeavors.

Key Highlights of Tigris Trial Enrollment

As of now, 157 patients have been enrolled in this substantial clinical trial, with 151 being assessed for efficacy. This remarkable participation showcases robust interest from both researchers and clinicians in the clinical utility of PMX.

Enrollment Details

The completion of enrollment signifies a milestone for the Company, with significant metrics outlining the outcomes:

  • Total Enrolled Patients: 157 total participants have been involved; among them, 151 patients will be evaluated, and 100 have received treatment with PMX.
  • Follow-Up Procedures: A 28-day follow-up for the final enrolled patient will be conducted, with completion anticipated by May 8, 2025.

Expected Outcomes from the Trial

Data analysis is structured to occur approximately 90 days post the last patient’s follow-up, with results expected to be released about two weeks after this data lock. The anticipation surrounding the topline results is high, as it could provide important insights into the efficacy of PMX.

Regulatory Advancements and PMA Submission

Following the completion of the Tigris trial enrollment, Spectral is intensifying its focus on regulatory processes related to PMX's Premarket Approval submission. This submission will utilize a modular approach, whereby non-clinical information has been submitted separately from clinical findings, enabling efficient review by the US Food and Drug Administration (FDA).

As of now, all necessary non-clinical studies and reports have been forwarded to the FDA for their consideration, with plans in place to submit clinical data by the close of October 2025.

Company Leadership Highlights

Dr. John Kellum, Chief Medical Officer, expressed appreciation for the involvement of patients and clinical sites that facilitated the rapid enrollment of participants. He emphasized the significance of the trial outcomes, noting that the results could potentially revolutionize treatment protocols for septic shock.

“Finalizing enrollment represents another major milestone for the Company and puts us on track towards our regulatory goal for PMX. We have a clear path ahead, and we remain committed to advancing our commercialization efforts in collaboration with our partners,” stated Chris Seto, CEO of Spectral.

Looking Ahead – Upcoming Corporate Update Call

In light of the Tigris trial’s success, the Company will host a corporate update call, scheduled for May 15, 2025, at 11:00 a.m. ET. During this call, leaders from Spectral will discuss the regulatory trajectory and provide insights into corporate funding.

All interested parties are encouraged to participate.

About Spectral Medical

Spectral is at the forefront of a major advancement within the medical field, actively seeking U.S. FDA approval for its innovative PMX product designed for the management of septic shock. PMX serves as a therapeutic hemoperfusion system that effectively removes endotoxins from the bloodstream, guided by the Company’s FDA-cleared Endotoxin Activity Assay (EAA™). This product holds significant promise, having been utilized successfully over 360,000 times across Japan and Europe.

With recent recognition from the FDA as a Breakthrough Device, PMX is positioned uniquely to address the urgent medical need; approximately 330,000 patients are diagnosed with septic shock in North America annually.

Frequently Asked Questions

What is the Tigris trial about?

The Tigris trial evaluates the effectiveness of Polymyxin B Hemoperfusion (PMX) in treating adults with endotoxic septic shock.

How many patients were enrolled in the Tigris trial?

A total of 157 patients have been enrolled in the Tigris trial.

When will the topline results be announced?

The topline results are expected to be released around two weeks after the data lock, which occurs approximately 90 days after the last patient's follow-up.

How is Spectral Medical addressing regulatory submissions?

Spectral is employing a modular approach for its Premarket Approval submission to facilitate efficient review by the FDA.

Where can I learn more about Spectral Medical?

For further information about Spectral Medical and its products, visit www.spectraldx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 225

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Debevoise Builds Its PE M&A Bench With McBain Hire

Updated Category News Views 55

Law-firm hiring rarely makes a market blink, yet this one carries a decent whiff of where the deal work is gathering. Debevoise & Plimpton has brought Jenna McBain into its New York Mergers & Acquisitions Group as a partner, putting another experienced private-equity adviser on a platform the firm plainly intends to keep enlarging. McBain arrives from Weil, Gotshal &...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 136

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 29

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 121

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 100

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Agriculture with Mainstay® Calcium 2.0 Certification

Updated Category News Views 105

Mainstay® Calcium 2.0 Achieves Certification Mainstay® Calcium 2.0 has earned its rightful place as a certified biostimulant, revolutionizing the agricultural landscape. This exciting development marks a significant milestone in enhancing crop health and productivity, driven by advanced agricultural research and innovation. The Importance of Biostimulants in Farming In...

Continue Reading
Discover the Impressive Growth of Viper Energy Stock Over Time

Updated Category News Views 132

Understanding Viper Energy's Stock Growth Viper Energy Inc (NASDAQ: VNOM) has demonstrated impressive performance over the last five years, surpassing the general market by a notable margin. With an annualized growth rate of 15.74%, the company has generated an average annual return of 30.08%. As it stands, Viper Energy boasts a market capitalization of approximately...

Continue Reading
Synthetic Rope Market Growth Driven by Diverse Applications

Updated Category News Views 244

Synthetic Rope Market Dynamics The global synthetic rope market is projected to experience significant growth, with estimates suggesting it could reach USD 3.07 billion by 2029. This growth is fueled by a compound annual growth rate (CAGR) of 6.7% from 2024 to 2029. Various applications across industries such as marine, fishing, oil & gas, as well as sports and leisure...

Continue Reading
Innovative Keg Cover Promises Convenience for Beer Lovers

Updated Category News Views 168

Introducing the HUG-A-BARREL: A Game-Changer for Events The HUG-A-BARREL is an innovative invention that transforms the way beer lovers enjoy their drinks during outdoor gatherings. Imagine a specially designed covering for beer kegs that not only keeps your favorite brews cold for hours but also eliminates the messy task of filling up a tub with ice. This invention is...

Continue Reading
Global Innovations Highlighted at the Successful COMEUP 2025 Festival

Updated Category News Views 116

Celebrating Success at COMEUP 2025 COMEUP 2025 wrapped up successfully, showcasing a blend of innovation and collaboration among startups from around the globe. This annual festival, organized by the Ministry of SMEs and Startups in South Korea, provided an invaluable platform for entrepreneurs to connect, collaborate, and innovate under the inspiring theme "Recode the...

Continue Reading